A novel evolutionarily conserved element is a general transcriptional repressor of p21WAF¹/CIP¹

Weiguo Xu1, Qi Zhu, Zhenghua Wu

  • 1School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.

Cancer Research
|October 16, 2012
PubMed

Insights

Oxaliplatin effectively induces p21 expression in p53-negative cancer cells by derepressing a conserved Sp1/Sp3 element in the p21 promoter. This finding offers a new strategy for cancer management by targeting this regulatory repressor.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genomics

Background:

  • Inducing p21 (WAF1/CIP1/Cdkn1a) expression is crucial for managing p53-negative cancers.
  • The precise mechanisms regulating p21 expression in these cells remain incompletely understood.

Purpose of the Study:

  • To investigate how common chemotherapeutic drugs, specifically oxaliplatin, induce p21 expression in p53-negative cancer cells.
  • To identify and characterize the regulatory elements and molecular mechanisms involved in oxaliplatin-mediated p21 induction.

Main Methods:

  • Utilized electrophoretic mobility shift and antibody super-shift assays to confirm Sp1/Sp3 binding to the p21 promoter.
  • Analyzed the ENCODE database to identify conserved regulatory elements within the p21 promoter.
  • Performed in vivo competition assays to assess the function of the identified Sp1/Sp3 palindrome element.

Main Results:

  • Oxaliplatin induces p21 expression by derepressing a novel negative regulatory element containing an Sp1/Sp3 palindrome in the p21 proximal promoter (-216 to -236).
  • Oxaliplatin treatment increases Sp1/Sp3 phosphorylation and binding affinity to this element, leading to p21 transcriptional derepression.
  • The Sp1/Sp3 palindrome is the only vertebrate-conserved element in the proximal p21 promoter, highlighting its functional significance.

Conclusions:

  • A conserved Sp1/Sp3 palindrome element in the p21 promoter acts as a repressor of basal p21 expression.
  • Oxaliplatin overcomes this repression through enhanced Sp1/Sp3 activity, providing a novel therapeutic target for p53-negative cancers.

Related Concept Videos

Cis-regulatory Sequences02:02

Cis-regulatory Sequences

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...